IFNA1 and COVID-19: The primary outcome measure was the evaluation of severity by the total severity score (TSS) and the CT severity score (CTSS) according to the presence or absence of anti-IFN auto-Abs.<h4>Results</h4>231 critically ill COVID-19 patients were included in the study (mean age 59.5±12.7 years; males 74.6%).